Below, we highlight seven insightful�articles circulating around the financial space this week:
How often is there a 10% pullback in a bull market? (Avondale Asset Management)What the decline in inventories held by gold ETFs �mean for investors (Acting Man)A closer look at companies decreasing dividends (Political Calculations)How to calculate risk in a rising rate environment�(Institutional Investor)Solar power benefiting from international trade�(VOX)The best and worst performers this earnings season (Think B.I.G.)How the U.S. is beating the global market (Charts etc.)Follow me on Twitter�@DPylypczak.
Top Integrated Utility Companies To Watch In Right Now: Nustar Energy L.P.(NS)
NuStar Energy L.P. engages in the terminalling, storage, and transportation of petroleum products primarily in the United States, Canada, the Netherlands, St. Eustatius in the Caribbean, the United Kingdom, and Mexico. The company operates in three segments: Storage, Transportation, and Asphalt and Fuels Marketing. The Storage segment operates terminal and storage facilities for petroleum products, specialty chemicals, crude oil, and other liquids; and crude oil storage tanks. Its terminals also offer pilotage, tug assistance, line handling, launch, emergency response, and other ship services. The Transportation segment transports refined petroleum products, crude oil, and anhydrous ammonia. This segment operates refined product pipelines in Texas, Oklahoma, Colorado, New Mexico, Kansas, Nebraska, Iowa, South Dakota, North Dakota, and Minnesota; and owns anhydrous ammonia pipelines located in Louisiana, Arkansas, Missouri, Illinois, Indiana, Iowa, and Nebraska. The Asphalt and Fuels Marketing segment refines crude oil to produce asphalt and other refined products. This segment also purchases gasoline and other refined petroleum products for resale. As of December 31, 2010, the company had 65 terminal and storage facilities providing approximately 80.4 million barrels of storage capacity; 5,605 miles of refined product pipelines with 21 associated terminals that offer storage capacity of 4.6 million barrels, as well as 2 tank farms providing storage capacity of 1.2 million barrels; 2,000 miles of anhydrous ammonia pipelines; 812 miles of crude oil pipelines with 16 associated storage tanks comprising storage capacity of 1.9 million barrels; and 2 asphalt refineries with a combined capacity of 104,000 barrels per day, as well as 2 associated terminal facilities with a combined storage capacity of 5.0 million barrels. Riverwalk Logistics, L.P. serves as the general partner of the company. NuStar Energy L.P. was founded in 1999 and is based in Sa n Antonio, Texas.
Advisors' Opinion:- [By Rich Smith]
Wrapping up a week most notable for its stinginess, the U.S. Department of Defense awarded only three (yes, you read that right) new contracts Friday. As for the $44 million in Pentagon contracts awarded, the winners were:
- [By Robert Rapier]
But it is important to note that ETE also has interests in Sunoco Logistics Partners (NYSE: SXL) and Regency Energy Partners (NYSE: RGP).
Finally, consider NuStar Energy (NYSE: NS) and its general partner NuStar GP Holdings (NYSE: NSH). Like ETE, NSH went public in 2006 and has also significantly outperformed its limited partner since:
The vast majority of partnerships don’t have a publicly-traded GP. But in each of these three cases in which the GP is publicly traded, the GP tends to outperform the LP units on long-term gains, an advantage somewhat offset by the typically higher LP yield.
Top Integrated Utility Companies To Watch In Right Now: Koss Corporation(KOSS)
Koss Corporation, together with its subsidiary, Koss Classics Ltd., designs, manufactures, and sells stereo headphones and related accessories primarily in the United States and Europe. It offers a line of high-fidelity stereo headphones, speaker-phones, computer headsets, telecommunications headsets, active noise canceling stereo headphones, wireless stereo headphones, and compact disc recordings of American Symphony Orchestras under the Koss Classics label. The company sells its products through national retailers, international distributors, audio specialty stores, the Internet, direct mail catalogs, regional department store chains, discount department stores, military exchanges, and prisons under the Koss name. It also sells its products to distributors for resale to school systems, and directly to other manufacturers. The company was founded in 1953 and is based in Milwaukee, Wisconsin.
Advisors' Opinion:- [By John Udovich]
Yesterday after the market closed, small cap audio stock Skullcandy Inc (NASDAQ: SKUL) reported earnings and began rising in after hours trading, meaning its worth taking a closer look at the stock along with the performance of other audio stocks like mid cap Harman International Industries Inc (NYSE: HAR) and small caps Koss Corporation (NASDAQ: KOSS) and Parametric Sound Corp (NASDAQ: PAMT). I should mention that in�late 2012, Skullcandy had the dubious distinction of being the market�� most shorted stock (see: Long Live the Shorts or the Short Squeeze? SKUL, AM & UBNT) with short�interest of 86.47% and there would still be a lot of shorts out there who might start feeling the squeeze (Note: SKUL is at least no longer on the HighShortInterest.com list)
- [By Jason Rivera]
Koss Corporation (KOSS) was no different because after looking over its balance sheet and profitability numbers I found substantial NOLs, little debt and reasonable profitability levels which usually are good signs that the company may be a good investment if the company is undervalued. This however is not an article about a company that I will ever invest in due to it being a grossly overvalued, dying company, which has major management concerns.
Best Integrated Utility Stocks To Own Right Now: Inovio Pharmaceuticals Inc (INO)
Inovio Pharmaceuticals, Inc., incorporated on June 29, 1983, is engaged in the development of a new generation of vaccines, called synthetic vaccines, focused on cancers and infectious diseases. The Company's SynCon technology enables the design of universal vaccines capable of providing cross-protection against existing or changing strains of pathogens, such as influenza and human immunodeficiency virus (HIV). The Company's electroporation delivery technology uses brief, controlled electrical pulses to increase cellular uptake of the vaccine. Its clinical programs include cervical dysplasia (therapeutic), avian influenza (preventive), prostate cancer (therapeutic), leukemia (therapeutic), hepatitis C virus (HCV) and HIV vaccines. It is advancing preclinical research and clinical development for a universal seasonal/pandemic influenza vaccine, as well as preclinical work for other products, including malaria and prostate cancer vaccines. Its partners and collaborators include University of Pennsylvania, Drexel University, National Microbiology Laboratory of the Public Health Agency of Canada, Program for Appropriate Technology in Health/Malaria Vaccine Initiative (PATH/MVI), National Institute of Allergy and Infectious Diseases (NIAID), Merck, ChronTech, University of Southampton, United States Military HIV Research Program (USMHRP), the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) and HIV Vaccines Trial Network (HVTN). As of December 31, 2011 it owned 16.1% interest in VGX Int��.
Inovio�� Solution
The Company�� synthetic vaccine platform consists of its SynCon vaccine design process and electroporation delivery technology. It has developed a preclinical and clinical stage pipeline of vaccines. The Company�� synthetic vaccines are designed to prevent a disease (prophylactic vaccines) or treat an existing disease (therapeutic vaccines). Its synthetic vaccine consists of a deoxyribonucleic acid (DNA) plasmid encoding a selected antigen! (s), which is introduced into cells of humans or animals with the purpose of evoking an immune response to the encoded antigen. The Company�� synthetic vaccines are designed to generate specific antibody and/or T-cell responses.
The Company�� SynCon technology provides processes that employ bioinformatics, which combine extensive genetic data and sophisticated algorithms. Its design process uses the genetic make-up of a common antigen(s) from multiple strains of a virus within a viral sub-type or taxonomic group (family) of pathogens, such as HIV, hepatitis C virus (HCV), human papillomavirus (HPV), influenza and other diseases to synthetically create a new antigen for the desired pathogen target that does not exist in nature. Its synthetic vaccine candidates are being delivered into cells of the body using its electroporation (EP) DNA delivery technology.
Cancer Synthetic Vaccines
The Company has two broad types of cancer vaccines: preventive (or prophylactic) vaccines, which are intended to prevent cancer from developing in healthy people, and treatment (or therapeutic) vaccines, which are intended to treat an existing cancer by strengthening the body�� natural defenses against the cancer. Two types of cancer preventive vaccines are available in the United States. The United States Food and Drug Administration (the FDA) has approved two vaccines, Gardasil and Cervarix that protect against infection by the two types of HPV-types 16 and 18-that cause approximately 70% of all cases of cervical cancer worldwide. In addition, Gardasil protects against infection by two additional HPV types, 6 and 11, which are responsible for about 90% of all cases of genital warts in males and females but do not cause cervical cancer.
Cervarix manufactured by GlaxoSmithKline, is composed of virus-like particles (VLPs) made with proteins from HPV types 16 and 18. Cervarix is approved for use in females��ages 10 to 25 for the prevention of cervical cancer caused by! HPV type! s 16 and 18. Gardasil manufactured by Merck, is approved for use in females for the prevention of cervical cancer, and some vulvar and vaginal cancers, caused by HPV types 16 and 18 and for use in males and females for the prevention of genital warts caused by HPV types 6 and 11. The vaccine is approved for these uses in females and males ages 9 to 26. The FDA has also approved a cancer preventive vaccine that protects against hepatitis B virus (HBV) infection.
Inovio�� VGX-3100 is designed to raise immune responses against the E6 and E7 genes of HPV types 16 and 18 that are present in both pre-cancerous and cancerous cells transformed by these HPV types. E6 and E7 are oncogenes that play an integral role in transforming HPV-infected cells into cancerous cells. In March 2011, it initiated a randomized, double-blind Phase II study of VGX-3100 delivered using the CELLECTRA intramuscular electroporation device in women with HPV Type 16 or 18 and diagnosed with, but not yet treated for, cervical intraepithelial neoplasia (CIN) 2/3. The study is designed to enroll 148 subjects. In January 2011, it announced the publication of a scientific paper in the journal Human Vaccines detailing potent immune responses in a preclinical study of its SynCon vaccine for prostate cancer targeting two antigens, prostate specific antigen (PSA) and prostate specific membrane antigen (PSMA).
In January 2011, the Company announced the regulatory approval of a Phase II clinical trial (WIN Trial) to treat leukemia utilizing its new ELGEN 1000 automated vaccine delivery device. The single dose level, Phase II study, called WT1 immunity via DNA fusion gene vaccination in haematological malignancies by intramuscular injection followed by intramuscular electroporation. Cancer Vaccines encodes for hTERT, an antigen related to non-small cell lung, breast and prostate cancers. The vaccine is delivered using its electroporation delivery technology.
Infectious Disease Synthetic Vaccines
In Marc! h 2011, the Company announced the initiation of a follow-on open label, single dose Phase II clinical study in collaboration with ChronTech of the ChronVac-C HCV DNA vaccine delivered using its electroporation technology in treatment naive HCV infected individuals. Its HIV vaccines consist of candidates for HIV prevention, as well as therapy or treatment. PENNVAX-B is designed to target HIV clade B (most commonly found in the United States, North America, Australia and the European Union (EU). PENNVAX-G is designed to target HIV clades A, C and D, which are more commonly found in Asia, Africa, Russia and South America. This Phase I clinical study of PENNVAX-B (HVTN-080) vaccinated 48 healthy, HIV-negative volunteers to assess safety and levels of immune responses generated by Inovio�� PENNVAX-B vaccine delivered with its CELLECTRA electroporation device. PENNVAX-B is a SynCon vaccine that targets HIV gag, pol, and env proteins.The Company�� VGX-3400X targets H5N1. The vaccine consists of three distinct DNA plasmids coded for a consensus hemagglutinin (HA) antigen derived from different H5N1 virus strains; a consensus neuraminidase (NA) antigen derived from different N1 sequences; and a consensus nucleoprotein (NP) fused to a small portion of the m2 protein (m2E) based on a broader cross-section of influenza viruses in addition to H5N1 and H1N1. Conventional vaccines are strain-specific and have limited ability to protect against genetic shifts in the influenza strains they target. They are therefore modified annually in anticipation of the next flu season�� new strain(s). It is focused on developing DNA-based influenza vaccines able to provide broad protection against known as well as newly emerging, unknown seasonal and pandemic influenza strains.
Animal Health/Veterinary
VGX Animal Health, Inc. (VGX AH), a majority-owned subsidiary, has licensed LifeTide, a plasmid-based growth hormone releasing hormone (GHRH) technology for swine. LifeTide is one of onl! y four DN! A-based treatments approved for use in animals and is the only DNA-based agent delivered using electroporation that has been granted marketing approval (Australia). VGX AH is also developing a GHRH-based treatment for cancer and anemia in dogs and cats. It is developing a synthetic vaccine for foot-and-mouth disease (FMD) administered by its vaccine delivery technology. The FMD virus is one of the most infectious diseases affecting farm animals, including cattle, swine, sheep and goats, and is a serious threat to global food safety.
The Company competes with Crucell N.V, Sanofi-Aventis, Novartis, Inc., GlaxoSmithKline plc, Merck, Pfizer, AstraZeneca, Inc., Novartis, Inc., MedImmune and CSL.
Advisors' Opinion:- [By Jake L'Ecuyer]
Equities Trading DOWN
Shares of Inovio Pharmaceuticals (NYSE: INO) were down on Friday's session, falling 13.28 percent to $2.488 despite seemingly little news on the company.
Top Integrated Utility Companies To Watch In Right Now: Sterling Construction Company Inc(STRL)
Sterling Construction Company, Inc., a heavy civil construction company, engages in the building, reconstruction, and repair of transportation and water infrastructure. Its transportation infrastructure projects include highways, roads, bridges, and light rail and commuter rail; and water infrastructure projects comprise water, wastewater, and storm drainage systems. The company also provides general contracting services, such as excavating, concrete and asphalt paving, installation of large-diameter water and wastewater distribution systems, construction of bridges and similar large structures, construction of light and commuter rail infrastructure, concrete and asphalt batch plant operations, and concrete crushing and aggregates operations. It serves public sector customers, including county and municipal public works departments, regional transit and water authorities, port authorities, school districts, and municipal utility districts, as well as private customers prim arily in Texas, Utah, Nevada, Arizona, and California. The company was formerly known as Oakhurst Company, Inc. and changed its name to Sterling Construction Company, Inc. in November 2001. Sterling Construction Company, Inc. was founded in 1954 and is headquartered in Houston, Texas.
Advisors' Opinion:- [By Laura Brodbeck]
Notable earnings releases expected on Monday include:
LAN Chile S.A. (NYSE: LFL) is expected to report fourth quarter EPS of $0.24 on revenue of $3.50 billion, compared to last year�� EPS of $0.02 on revenue of $3.48 billion. JA Solar Holdings, Co. Ltd (NASDAQ: JASO) is expected to report EPS of $0.03 on revenue of $291.75 million, compared to last year�� loss of $2.65 per share on revenue of $268.09 million. Sterling Construction Company, Inc�(NASDAQ: STRL) is expected to report a fourth quarter loss of $1.47 per share on revenue of $153.07 million, compared to last year�� EPS of $0.18 on revenue of $158.09 million.Economics
Top Integrated Utility Companies To Watch In Right Now: St. Joe Co (JOE)
The St. Joe Company, incorporated on May 26, 1936, owns land, timber and resort assets located primarily in Northwest Florida, Jacksonville, Florida and Tallahassee, Florida. The Company operates in five segments: residential real estate, commercial real estate, resorts, leisure and leasing operations, forestry, and rural land. Its residential real estate segment plans and develops mixed-use resort, primary and seasonal residential communities of various sizes, primarily on the Company's existing land. In the Company's commercial real estate segment the Company plans, develops, manages and sells real estate for commercial purposes. Its leisure and leasing operations includes the Company's resorts and clubs financial information, which was presented in the residential real estate segment. The Company owns and operates forestry operations in the Southeastern United States. It traditionally sells parcels of varying sizes ranging from less than one acre to thousands of acres.
Residential Real Estate
The Company owns large tracts of land in Northwest Florida, including Gulf of Mexico beach frontage, and other waterfront properties and land in and around Jacksonville and Tallahassee. Within the Company's residential real estate business, the Company has two types of communities and is planning to add a third type. The first, the Company's residential resort communities, are positioned to attract primarily second home buyers. The Company's l projects in this category include the WaterColor and WaterSound Beach communities, which were built in a region of Florida. The Company's second category of residential communities is the Company's primary home communities for buyers who will use the community as their primary residence. The Breakfast Point, RiverTown and SouthWood communities are the Company's largest projects in this category. The Company's third category of residential communities is active adult communities.
Commercial Real Estate
The Company focuse! s on commercial development and sales in Northwest Florida because of its large land holdings surrounding the new Northwest Florida Beaches International Airport (the Airport), along roadways and near or within business districts in the region. The Company provides development opportunities for national and regional retailers and its strategic partners in Northwest Florida. The Company offers land for commercial and light industrial uses within large and small-scale commerce parks, as well as a range of multi-family rental projects. The Company also develops commercial parcels within or near existing residential development projects.
Resorts, Leisure and Leasing Operations
The Company's leasing operations were presented in both its residential real estate and commercial real estate segments. The Company's resorts, leisure and leasing operations segment includes recurring revenue streams from the Company's resort and leisure businesses and its leasing operations. The Company's WaterColor Inn and Resort is a boutique hotel, which provides guests with a beach club, spa, tennis center, restaurant and complementary retail and commercial space. The day-to-day operations of the WaterColor Inn and Resort is managed by Noble House Hotels & Resorts. In addition the Company's vacation rental business rents private homes in the WaterColor community and surrounding communities, primarily in those that the Company has built, to individuals who are vacationing in the area. The Company does not own the homes, but for a fee, the Company advertises , take reservations, check-in and check-out , and clean and maintains the home for the homeowner. The Company owns four golf courses in Northwest Florida. Three of them are in the Panama City Beach area and the fourth is located in Tallahassee. The golf courses are situated in or near the Company's residential communities. The Company also own two marinas. The Company's golf courses and marinas are managed for the Company by a third party management c! ompanies.!
The Company's leasing operations business includes the Company's retail and commercial leasing. The Company has several small retail shopping centers located in or near to some of its residential projects, such as the WaterColor, SouthWood and WindMark Beach communities that are managed by its leasing team. The Company's commercial leasing business includes industrial parks and several commerce parks. One of the industrial parks is the Company's VentureCrossings Enterprise Centre, a 1,000 acre commercial and industrial development adjacent to the Airport.
Forestry
The Company has 545,000 acres designated for forestry operations, including land in West Bay. Southern Pine, the Company's main product, is a product that fits well into cost-conscience supply chains. The Company's forestry operations can produce about 1.3 million tons of trees for lumber and pulp on an annual, sustainable basis. The Company rigorously examines the characteristics of individual trees in a forest and the interactions of those trees with each other and with the forest ecosystem as a whole in order to maximize the timber output. The Company produces both sawtimber (lumber used in construction) and pulp (timber used to make pulp for products like linerboard).
Rural Land
The majority of rural land sold is undeveloped timberland and is managed as timberland until sold, although some parcels include the benefits of limited development activity, including improved roads, ponds and fencing. The pricing of these parcels varies significantly based on size, location, terrain, timber quality and other local factors.
Advisors' Opinion:- [By Ben Levisohn]
Their advice: Cover your shorts. That means they’ve upgraded DR Horton and KB Homes to Market Peform from Underperform. And if our idea of a good time is playing the upside in a potential short squeeze, then they have the stocks for you, too–Lennar and the St. Joe Co. (JOE), which have short-interest ratios of 25.3% and 14.3%, respectively. “For investors needing a little more excitement in their lives, we are also upgrading two names that we believe could uncommonly benefit from potential short-covering if ��ope Trade 2014��gains momentum,” Horne writes. Lennar goes to Strong Buy from Outperform and St. Joe goes to Outperform from Market Perform.
- [By Monica Wolfe]
St. Joe Corporation (JOE)
Bruce Berkowitz�� fourth largest holding is in St. Joe Corporation where he holds 6.8% of his total portfolio. As of the second quarter, the guru owned 25,017,933 shares of St. Joe, representing 27.10% of the company�� shares outstanding.
No comments:
Post a Comment